Your browser doesn't support javascript.
loading
Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide.
Greene, John; Baird, Anne-Marie; Casey, Orla; Brady, Lauren; Blackshields, Gordon; Lim, Marvin; O'Brien, Odharnaith; Gray, Steven G; McDermott, Raymond; Finn, Stephen P.
Afiliação
  • Greene J; Department of Histopathology and Morbid Anatomy, School of Medicine, Trinity College Dublin, Dublin 8, Ireland. greenejo@tcd.ie.
  • Baird AM; Department of Medical Oncology, Tallaght Hospital, Dublin 24, Ireland. greenejo@tcd.ie.
  • Casey O; Department of Histopathology and Morbid Anatomy, School of Medicine, Trinity College Dublin, Dublin 8, Ireland.
  • Brady L; Thoracic Oncology Research Group, Trinity Translational Medical Institute, St. James's Hospital, Dublin 8, Ireland.
  • Blackshields G; Department of Clinical Medicine, Trinity College Dublin, Dublin 2, Ireland.
  • Lim M; Cancer and Ageing Research Program, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.
  • O'Brien O; Department of Histopathology and Morbid Anatomy, School of Medicine, Trinity College Dublin, Dublin 8, Ireland.
  • Gray SG; Department of Histopathology and Morbid Anatomy, School of Medicine, Trinity College Dublin, Dublin 8, Ireland.
  • McDermott R; Department of Histopathology and Morbid Anatomy, School of Medicine, Trinity College Dublin, Dublin 8, Ireland.
  • Finn SP; Department of Histopathology and Morbid Anatomy, School of Medicine, Trinity College Dublin, Dublin 8, Ireland.
Sci Rep ; 9(1): 10739, 2019 07 24.
Article em En | MEDLINE | ID: mdl-31341219

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Feniltioidantoína / Neoplasias da Próstata / RNA Circular / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Sci Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irlanda

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Feniltioidantoína / Neoplasias da Próstata / RNA Circular / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Sci Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irlanda